BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 32741485)

  • 1. Aggressive Pituitary Adenomas and Carcinomas.
    Ilie MD; Jouanneau E; Raverot G
    Endocrinol Metab Clin North Am; 2020 Sep; 49(3):505-515. PubMed ID: 32741485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. World Health Ozganization 2017 Classification of Pituitary Tumors.
    Lopes MBS
    Endocrinol Metab Clin North Am; 2020 Sep; 49(3):375-386. PubMed ID: 32741477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016.
    McCormack A; Dekkers OM; Petersenn S; Popovic V; Trouillas J; Raverot G; Burman P;
    Eur J Endocrinol; 2018 Mar; 178(3):265-276. PubMed ID: 29330228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas.
    Dai C; Liang S; Sun B; Kang J
    Front Endocrinol (Lausanne); 2020; 11():608422. PubMed ID: 33362722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definition and diagnosis of aggressive pituitary tumors.
    Kasuki L; Raverot G
    Rev Endocr Metab Disord; 2020 Jun; 21(2):203-208. PubMed ID: 31808044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas.
    Raverot G; Burman P; McCormack A; Heaney A; Petersenn S; Popovic V; Trouillas J; Dekkers OM;
    Eur J Endocrinol; 2018 Jan; 178(1):G1-G24. PubMed ID: 29046323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant pituitary tumours.
    Kaltsas GA; Grossman AB
    Pituitary; 1998 Apr; 1(1):69-81. PubMed ID: 11081185
    [No Abstract]   [Full Text] [Related]  

  • 8. Approach to the Treatment of a Patient with an Aggressive Pituitary Tumor.
    Lin AL; Donoghue MTA; Wardlaw SL; Yang TJ; Bodei L; Tabar V; Geer EB
    J Clin Endocrinol Metab; 2020 Dec; 105(12):3807-20. PubMed ID: 32930787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aggressive pituitary adenoma and pituitary carcinoma].
    Tóth M
    Orv Hetil; 2023 Jul; 164(30):1167-1175. PubMed ID: 37516994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive pituitary tumours and carcinomas: two sides of the same coin?
    Trouillas J; Burman P; McCormack A; Petersenn S; Popovic V; Dekkers O; Raverot G
    Eur J Endocrinol; 2018 Jun; 178(6):C7-C9. PubMed ID: 29588294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology of aggressive pituitary tumors (and its challenges).
    Dekkers OM; Karavitaki N; Pereira AM
    Rev Endocr Metab Disord; 2020 Jun; 21(2):209-212. PubMed ID: 32361816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of pituitary carcinomas and atypical pituitary adenomas: a review.
    Hirohata T; Ishii Y; Matsuno A
    Neurol Med Chir (Tokyo); 2014; 54(12):966-73. PubMed ID: 25446382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive pituitary adenomas: significance of proliferation parameters.
    Amar AP; Hinton DR; Krieger MD; Weiss MH
    Pituitary; 1999 Aug; 2(2):117-22. PubMed ID: 11081161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary Tumors Centers of Excellence.
    Frara S; Rodriguez-Carnero G; Formenti AM; Martinez-Olmos MA; Giustina A; Casanueva FF
    Endocrinol Metab Clin North Am; 2020 Sep; 49(3):553-564. PubMed ID: 32741488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinician's questions.
    Trouillas J; Jaffrain-Rea ML; Vasiljevic A; Dekkers O; Popovic V; Wierinckx A; McCormack A; Petersenn S; Burman P; Raverot G; Villa C
    Rev Endocr Metab Disord; 2020 Jun; 21(2):243-251. PubMed ID: 32504268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory pituitary adenoma: a novel classification for pituitary tumors.
    Dai C; Feng M; Liu X; Ma S; Sun B; Bao X; Yao Y; Deng K; Wang Y; Xing B; Lian W; Zhong D; Ma W; Wang R
    Oncotarget; 2016 Dec; 7(50):83657-83668. PubMed ID: 27845901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary carcinoma: diagnosis and treatment.
    Lopes MB; Scheithauer BW; Schiff D
    Endocrine; 2005 Oct; 28(1):115-21. PubMed ID: 16311418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive pituitary adenomas--diagnosis and emerging treatments.
    Di Ieva A; Rotondo F; Syro LV; Cusimano MD; Kovacs K
    Nat Rev Endocrinol; 2014 Jul; 10(7):423-35. PubMed ID: 24821329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.
    Thapar K; Scheithauer BW; Kovacs K; Pernicone PJ; Laws ER
    Neurosurgery; 1996 Apr; 38(4):765-70; discussion 770-1. PubMed ID: 8692397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodality treatment for invasive pituitary adenomas.
    Hornyak M; Couldwell WT
    Postgrad Med; 2009 Mar; 121(2):168-76. PubMed ID: 19332975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.